Oklahoma · 2025 Regular Session · Bill

HB 1416: Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Passed one chamber Last action April 1, 2025: Second Reading referred to Health and Human Services Committee then to Appropriations Committee

Plain-language summary

HB 1416 is a bill introduced in the Oklahoma House on February 3, 2025. According to its official title, it concerns: Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date. Primary sponsor: Paul Rosino (Republican), Josh West (Republican). Most recent recorded action (April 1, 2025): Second Reading referred to Health and Human Services Committee then to Appropriations Committee.

Sponsors

Primary sponsors: Paul Rosino (Republican); Josh West (Republican).